An investigation for investors in Rockwell Medical, Inc. (NASDAQ: RMTI) shares over potential securities laws violations by Rockwell Medical, Inc. was announced.
San Diego, CA -- (SBWIRE) -- 06/06/2018 -- An investigation was announced for investors of Rockwell Medical, Inc. (NASDAQ: RMTI) shares over potential securities laws violations by Rockwell Medical, Inc.
Investors who purchased shares of Rockwell Medical, Inc. (NASDAQ: RMTI), have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Rockwell Medical, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Wixom, MI based Rockwell Medical, Inc. reported that its annual Total Revenue rose from $53.28 million in 2016 to $57.3 million in 2017 and that its Net Loss increased from $19.8 million in 2016 to $25.92 million in 2017.
On May 22, 2018, Rockwell Medical, Inc announced that the Company's President and Chief Executive Officer, Robert Chioini, had been terminated from his positions, effective immediately. However, on May 23, 2018, a letter to shareholders was published on behalf of Mr. Chioini explaining that Mr. Chioini had called an emergency Board meeting for the purpose of discussing alleged breaches of fiduciary duties and other possible violations of securities laws by various directors the Company, and that those directors whose conduct was the subject of the alleged breaches of fiduciary duties voted to fire Mr. Chioini.
Those who purchased shares of Rockwell Medical, Inc. (NASDAQ: RMTI) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels